The past and the future of Alzheimer’s disease fluid biomarkers

Manuscript Number: 

17-0773R1

Author(s): 
Kaj Blennow, Henrik Zetterberg

Disclosures

Kaj Blennow

  • Consulting Fees:
    Fujirebio Europe, IBL International, Roche Diagnostics
    Equity:
    co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg.

Henrik Zetterberg

  • Equity:
    HZ is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg.